TD Private Client Wealth’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $178K | Sell |
2,580
-331
| -11% | -$22.8K | ﹤0.01% | 661 |
|
|
2025
Q1 | $202K | Sell |
2,911
-103
| -3% | -$7.15K | 0.01% | 593 |
|
|
2024
Q4 | $259K | Sell |
3,014
-1,544
| -34% | -$133K | 0.01% | 550 |
|
|
2024
Q3 | $543K | Sell |
4,558
-358
| -7% | -$42.6K | 0.02% | 444 |
|
|
2024
Q2 | $702K | Sell |
4,916
-2,240
| -31% | -$320K | 0.02% | 396 |
|
|
2024
Q1 | $919K | Sell |
7,156
-6,115
| -46% | -$785K | 0.03% | 360 |
|
|
2023
Q4 | $1.37M | Sell |
13,271
-3,032
| -19% | -$314K | 0.05% | 286 |
|
|
2023
Q3 | $1.48M | Buy |
16,303
+1,781
| +12% | +$162K | 0.06% | 257 |
|
|
2023
Q2 | $1.18M | Buy |
14,522
+6,622
| +84% | +$536K | 0.05% | 304 |
|
|
2023
Q1 | $629K | Sell |
7,900
-1,934
| -20% | -$154K | 0.03% | 399 |
|
|
2022
Q4 | $665K | Sell |
9,834
-286
| -3% | -$19.4K | 0.03% | 382 |
|
|
2022
Q3 | $504K | Sell |
10,120
-120
| -1% | -$5.98K | 0.03% | 402 |
|
|
2022
Q2 | $571K | Buy |
10,240
+4,846
| +90% | +$270K | 0.03% | 394 |
|
|
2022
Q1 | $300K | Sell |
5,394
-924
| -15% | -$51.3K | 0.01% | 495 |
|
|
2021
Q4 | $354K | Buy |
6,318
+234
| +4% | +$13.1K | 0.01% | 470 |
|
|
2021
Q3 | $292K | Buy |
6,084
+2,078
| +52% | +$99.8K | 0.01% | 477 |
|
|
2021
Q2 | $168K | Sell |
4,006
-382
| -9% | -$16K | 0.01% | 545 |
|
|
2021
Q1 | $148K | Sell |
4,388
-700
| -14% | -$23.6K | 0.01% | 545 |
|
|
2020
Q4 | $178K | Sell |
5,088
-3,782
| -43% | -$132K | 0.01% | 495 |
|
|
2020
Q3 | $308K | Sell |
8,870
-1,502
| -14% | -$52.1K | 0.02% | 411 |
|
|
2020
Q2 | $340K | Sell |
10,372
-6,230
| -38% | -$204K | 0.02% | 393 |
|
|
2020
Q1 | $500K | Buy |
16,602
+3,892
| +31% | +$117K | 0.04% | 321 |
|
|
2019
Q4 | $368K | Buy |
+12,710
| New | +$368K | 0.02% | 388 |
|